S, G., I, S., & S, R. (2026). Rational Design, Optimization and Bioinformatic Analysis of Anti-PD-L1 Peptide Conjugated Mocetinostat Prodrug Nanoparticles for Predictive Cancer Chemoimmunotherapeutic Efficacy. Pharmaceutical research, 43(6), 1979. https://doi.org/10.1007/s11095-026-04115-2
Chicago Style (17th ed.) CitationS, Gayen, Sanyal I, and Roy S. "Rational Design, Optimization and Bioinformatic Analysis of Anti-PD-L1 Peptide Conjugated Mocetinostat Prodrug Nanoparticles for Predictive Cancer Chemoimmunotherapeutic Efficacy." Pharmaceutical Research 43, no. 6 (2026): 1979. https://doi.org/10.1007/s11095-026-04115-2.
MLA (9th ed.) CitationS, Gayen, et al. "Rational Design, Optimization and Bioinformatic Analysis of Anti-PD-L1 Peptide Conjugated Mocetinostat Prodrug Nanoparticles for Predictive Cancer Chemoimmunotherapeutic Efficacy." Pharmaceutical Research, vol. 43, no. 6, 2026, p. 1979, https://doi.org/10.1007/s11095-026-04115-2.